Obesity Management Today:

Program Goals

Older Antiobesity Medications

Newly Approved Antiobesity Medications

Antiobesity Medications in Development

NHANES 2007-2008 Data on Obesity Management

American Medical Association: Obesity Is a Disease

Newly Approved Antiobesity Medications

Lorcaserin: Findings from the BLOOM Trial*

Lorcaserin: Findings from the BLOOM-DM Trial*

Topiramate/Phentermine: Findings from the CONQUER Trial*

Topiramate/Phentermine: Cardiometabolic Effects

Therapeutic Approaches: NIH/NHLBI Recommendations

Laboratory Testing

Pharmacologic Treatment for Obesity

Physician Barriers to Obesity Treatment

Starting the Weight Loss Discussion

Motivational Interviewing

Helping Patients Lose Weight

Assessing Patient Readiness and Resources

Set Realistic Goals

Assessing Patient Readiness for Weight Loss

Individualizing Weight Loss Treatmenta

Individualizing Weight Loss Treatment (cont)

Conclusions and Key Messages

Abbreviations

References

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)